TY - JOUR
T1 - Optical coherence tomography
T2 - A quantitative tool to measure neurodegeneration and facilitate testing of novel treatments for tissue protection in multiple sclerosis
AU - Gordon-Lipkin, Eliza
AU - Calabresi, Peter
PY - 2017/3/15
Y1 - 2017/3/15
N2 - Optical coherence tomography (OCT) is a relatively new imaging technology that has been introduced as a powerful biomarker in neurological disease, including multiple sclerosis. In this review, OCT as an imaging technique, its reproducibility and validation in multiple sclerosis, application to other neurodegenerative diseases and future technological directions are discussed.
AB - Optical coherence tomography (OCT) is a relatively new imaging technology that has been introduced as a powerful biomarker in neurological disease, including multiple sclerosis. In this review, OCT as an imaging technique, its reproducibility and validation in multiple sclerosis, application to other neurodegenerative diseases and future technological directions are discussed.
KW - Multiple sclerosis
KW - Neurodegeneration
KW - Neuroimaging
KW - Optical coherence tomography
UR - http://www.scopus.com/inward/record.url?scp=85009355123&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85009355123&partnerID=8YFLogxK
U2 - 10.1016/j.jneuroim.2016.12.003
DO - 10.1016/j.jneuroim.2016.12.003
M3 - Article
C2 - 28038893
AN - SCOPUS:85009355123
SN - 0165-5728
VL - 304
SP - 93
EP - 96
JO - Journal of Neuroimmunology
JF - Journal of Neuroimmunology
ER -